Rational engineering of a functional CpG-free ITR for AAV gene therapy

X Pan, Y Yue, M Boftsi, LP Wasala, NT Tran, K Zhang… - Gene therapy, 2022 - nature.com
Inverted terminal repeats (ITRs) are the only wild-type components retained in the genome
of adeno-associated virus (AAV) vectors. To determine whether ITR modification is a viable …

Novel application of trimethyl chitosan as an adjuvant in vaccine delivery

A Malik, M Gupta, V Gupta, H Gogoi… - International Journal of …, 2018 - Taylor & Francis
The application of natural carbohydrate polysaccharides for antigen delivery and its
adjuvanation potential has garnered interest in the scientific community in the recent years …

Innovative strategies for co-delivering antigens and CpG oligonucleotides

Y Krishnamachari, AK Salem - Advanced drug delivery reviews, 2009 - Elsevier
Cytosine–phosphorothioate–guanine oligodeoxynucleotides (CpG ODN) is a recent class of
immunostimulatory adjuvants that includes unmethylated CpG dinucleotide sequences …

CpG DNA and LPS induce distinct patterns of activation in human monocytes

G Hartmann, AM Krieg - Gene therapy, 1999 - nature.com
A specific set of immune functions is switched on in response to DNA containing
unmethylated CpG dinucleotides in particular base contexts ('CpG motifs'). Plasmids, viral …

Silica nanoparticle as a lymph node targeting platform for vaccine delivery

M An, M Li, J Xi, H Liu - ACS applied materials & interfaces, 2017 - ACS Publications
Nanoparticles have emerged as the platform of choice to improve the efficacy and safety of
subunit vaccines. A major challenge underlying the use of nanomaterials in vaccines lies in …

Toll-like receptor 9, CpG DNA and innate immunity

AA Ashkar, KL Rosenthal - Current molecular medicine, 2002 - ingentaconnect.com
Innate immunity provides the first line of defense against invading pathogens and is
essential for survival in the absence of adaptive immune responses. Innate immune …

The promise of nucleic acid vaccines

NP Restifo, H Ying, L Hwang, WW Leitner - Gene therapy, 2000 - nature.com
Establishing the effective use of 'naked'nucleic acids as vaccines would undoubtedly be one
of the most important advances in the history of vaccinology. While nucleic acids show much …

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides

AM Krieg - Biochimica et Biophysica Acta (BBA)-Gene Structure …, 1999 - Elsevier
Immune stimulation has been widely recognized as an undesirable side effect of certain
antisense oligodeoxynucleotides (ODN) which can interfere with their therapeutic …

Methods for enhancing antibody-induced cell lysis and treating cancer

G Weiner, G Hartmann - US Patent 7,534,772, 2009 - Google Patents
US7534772B2 - Methods for enhancing antibody-induced cell lysis and treating cancer -
Google Patents US7534772B2 - Methods for enhancing antibody-induced cell lysis and …

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12-and IFN-γ-dependent mechanisms

PS Walker, T Scharton-Kersten… - Proceedings of the …, 1999 - National Acad Sciences
Resistance to murine leishmaniasis correlates with development of a CD4+ T helper 1 (Th1)-
predominant immune response. To determine whether immunostimulatory CpG-containing …